Mutations in GLI3, which encodes a transcription factor of the Hedgehog signaling pathway, cause several developmental anomalies linked to inappropriate tissue patterning. Here, we report a novel missense variant in the fifth zinc finger domain of GLI3 (c.1826G>A; p.(Cys609Tyr)) initially identified in a proband with preaxial polydactyly type IV, developmental delay, sensorineural hearing loss, skeletal, and genitourinary anomalies. Additional family members exhibited various digital anomalies such as preaxial polydactyly, syndactyly, and postaxial polydactyly either in isolation or combined. Functional studies of Cys609Tyr GLI3 in cultured cells showed abnormal GLI3 processing leading to decreased GLI3 repressor production, increased basal transcriptional activity, and submaximal GLI reporter activity with Hedgehog pathway activation, thus demonstrating an intriguing molecular mechanism for this GLI3-related phenotype. Given the complexity of GLI3 post-translational processing and opposing biological functions as a transcriptional activator and repressor, our findings highlight the importance of performing functional studies of presumed GLI3 variants. This family also demonstrates how GLI3 variants are variably expressed.
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GLI3 is one of three GLI transcription factors of the canonical Hedgehog (HH) signaling pathway, and is an essential regulator of development and tissue patterning (Hui & Angers, 2011) . Numerous pathogenic variants of the GLI3 gene have been linked to complex clinical phenotypes. GLI3-related phenotypes include Greig cephalopolysyndactyly syndrome (GCPS, MIM175700), PallisterHall syndrome (PHS, MIM146510), non-syndromic postaxial polydactyly type A1 and B (PAP-A/B, MIM174200), and preaxial polydactyly type IV (PPD-IV, MIM174700) (Biesecker, 2006) . Classic GCPS is characterized by the triad of widely spaced eyes, macrocephaly, and PPD-IV or mixed pre-and postaxial polysyndactyly in at least one limb (Balk & Biesecker, 2008; Johnston et al., 2010) . PHS is described as an association of mesoaxial or PAP-A/B with hypothalamic hamartoma, though patients can also present with some combination of bifid epiglottis, non-digit skeletal defects, anorectal or genitourinary malformations, and sensorineural hearing loss (SNHL) (Hall et al., 1980; Johnston et al., 2010; Narumi et al., 2010) . Mild forms of GCPS and PHS can also be incorrectly diagnosed as isolated polydactyly and syndactyly. Consistent with their distinct phenotypes, GCPS and PHS patients can be categorized by discrete sets of genotypes that differentially affect GLI3 function ( Figure 1a ) (Demurger et al., 2015; Jamsheer et al., 2012; Johnston et al., 2010) . The GCPS phenotype is proposed to result from GLI3 haploinsufficiency, due to exonic or gene deletions, early truncation, loss of DNA binding (including point mutations in the zinc finger domains) as well as loss of transactivation. In contrast, changes that result in a constitutive GLI3R activity are thought to result in PHS (Johnston et al., 2010; Kalff-Suske et al., 1999) .
Here, we report a novel GLI3 missense variant in a family that caused a spectrum of digital anomalies. All affected individuals that were tested harbored a c.1826G>A (p.(Cys609Tyr)) variant in GLI3.
Functional studies of the murine p.Cys609Tyr GLI3 showed that the mutant protein is not efficiently processed to GLI3R, resulting in a fulllength protein with basal transcriptional activity and submaximal pathway activation.
| MATERIALS AND METHODS

| Patients
Subjects were enrolled in a research study approved by the institutional review boards of Stanford University School of Medicine.
| GLI3 sequencing
Clinical sequencing of GLI3 for the proband was performed through Prevention Genetics laboratories (Wisconsin). For other individuals, genomic DNA was extracted from saliva, the region of interest was amplified by PCR, purified and sequenced using standard techniques.
| Plasmid construction
The p3xFLAG-GLI3 and p3xFLAG-GLI3R expression constructs were previously described (Rack et al., 2014) . The p3xFLAG-GLI3C609Y construct was generated using standard site-directed mutagenesis.
| Luciferase reporter assays
Gli3 −/− mouse embryonic fibroblast (MEF) cells were provided by W.
Bushman (University of Wisconsin-Madison) and were cultured using standard media. The cells were transfected with control or p3xFLAG-GLI3, p8xGliBS-FL (GLI-dependent firefly luciferase), and phRL-SV40
(constitutive Renilla luciferase). Luciferase activities were measured using a Dual-Luciferase Reporter system (Promega, Madison, WI) on a Veritas luminometer (Turner Biosystems, Sunnyvale, CA).
| Immunoblotting
Transfected Gli3 −/− MEFs were lysed 48 or 72 h after transfection and western blotting was performed using a standard protocol. GLI3 was detected using anti-GLI3 primary antibody (goat polyclonal, R&D systems, AF3690), and HRP-conjugated bovine anti-goat secondary antibody (Jackson ImmunoResearch, . Band intensities were quantified using ImageJ software.
For full details on sequencing, plasmids, luciferase reporter assays, and immunoblotting, see supplementary online material.
3 | RESULTS
| Clinical report
The proband was a 5-year-old first-born daughter of unrelated Mexican-American parents at the time of our examination. She was delivered at 28 weeks by cesarean due to severe ascites. Her growth parameters adjusted for gestational age were: weight = 1.249 g (79th centile) and length = 35.5 cm (45th centile). The ascites was due to a cloacal anomaly consisting of absent urethral and vaginal openings and an anteriorly placed anus. She also had a tethered cord. She spent the first three months in the intensive care unit. Her urogenital anomalies were repaired, and at five years of age she was potty-trained for stool but had persistent encopresis and a neurogenic bladder. She had asymmetric kidneys, with the right kidney shorter than the left.
Skeletal anomalies included 13 ribs on both sides and a protruding lower rib cage on the left. She had moderate-to-severe bilateral SNHL, as well as mild motor and language delays. On exam, she was found to have widely spaced eyes (Interpupillary distance (IPD) = 6.5 cm; >97th centile [Gripp, 2013] ), a prominent forehead and wide nasal bridge, and toe anomalies consisting of left PPD-IV, right broad hallux, 2-3 toe cutaneous syndactyly and bilateral short and overlapping fourth toes The C2H2 zinc finger DNA-binding regions of GLI3 are highly conserved across the mammalian class (Figure 1c) , suggesting that the Cys609Tyr amino acid change could be deleterious (Takafumi, Makiko, & Kiyoshi, 2003) . To understand the effect of this missense change in protein function, we used site-directed mutagenesis to create the murine variant, and transiently overexpressed it in cultured mouse embryonic fibroblasts lacking endogenous Gli3 (Gli3 −/− MEFs).
The cells were also co-transfected with a GLI-dependent firefly luciferase reporter, and then cultured in the absence or presence of SHH-N ligand. Due to loss of GLI3R function, Gli3 −/− MEFs exhibit constitutive HH pathway activity, which can be enhanced further with SHH-N stimulation. As expected, overexpression of either wild-type GLI3 or GLI3R inhibited both basal and SHH-N-stimulated GLI reporter activity in these cells, with GLI3R exhibiting a greater suppressive effect ( Figure 1d) . Surprisingly, the GLI3 p.Cys609Tyr variant moderately elevated GLI reporter levels in non-stimulated
Gli3
−/− MEFs relative to the EGFP control, indicating that the mutant acts primarily as a transcriptional activator rather than a repressor.
Consistent with this result, western blot analyses of the transfected
Gli3
−/− MEFs demonstrated that overexpressed wild-type GLI3 is processed efficiently into GLI3R, but the Cys609Tyr mutant is not (Figure 1e ). However, we also observed that expression of GLI3 p.
Cys609Tyr prevented maximal SHH-N-induced GLI reporter activity in comparison to EGFP (Figure 1d ). Taken together, these results suggest that the Cys609Tyr mutant is a weak transcriptional activator that might competitively suppress HH target gene expression mediated by the other GLI proteins.
| DISCUSSION
By genotyping a large family with digit anomalies, we identified a novel c.1826G>A variant in GLI3. The pathogenicity of this variant is supported by: 1) its absence from population databases, 2) its cosegregation with affected kindred, 3) multiple computational programs predicted as deleterious, 4) its location in a critical and well-established functional domain of the protein, and 5) its abnormal transcriptional activity and proteolytic processing in functional studies. Accordingly, this variant can be conservatively classified as likely pathogenic (Richards et al., 2015) . The phenotype was found to have variable expressivity. Expect for the proband, family members had only apparent digit anomalies. However, mild forms of GCPS could have been missed due to the lack of comprehensive phenotyping of all individuals.
Cysteine 609 is one of the residues that directly coordinates a Zn 2+ ion in the fifth zinc finger domain of GLI3. Accordingly, the p.
Cys609Tyr variant would be expected to have diminished DNA binding, as postulated for a similar GLI3 variant, p.His601Arg (Volodarsky, Langer, & Birk, 2014) . As GLI3 has both transcriptional repressor and activator functions, disrupting a zinc finger domain could interfere with either or both activities. Expression of GLI3 p.Cys609Tyr in cultured MEFs lacking endogenous Gli3 showed that the mutant protein increased basal levels of GLI-dependent transcription, an observation potentially explained by the inability of GLI3 mutant to be processed into its repressor form. To our knowledge, a role for the zinc finger domains in the regulation of GLI3 post-translational processing has not been previously reported. The fifth zinc finger domain is proximal to the processing domain, and we speculate that the Cys609Tyr mutation may lead to conformational changes that impede processing domain recognition and GLI3 proteolysis.
We propose that individuals heterozygous for GLI3 c.1826G>A
could be functionally haploinsufficient with respect to GLI3R, explaining why the proband and other affected family members in this study have the limb anomalies more typically described in GCPS.
Our data further suggest that the Cys609Tyr mutation not only abrogates GLI3R production, but generates a weak transcriptional activator that can possibly competitively inhibit GLI2 and GLI1 function in cells.
The proband had additional findings of SNHL, non-digit skeletal anomalies, renal, and genital malformations. One explanation is that the additional findings are unrelated to the GLI3 variant. An alternative hypothesis is that the proband may have additional genetic or environmental factors that suppressed HH signaling function in the affected tissues, which in combination with the GLI3 c.1826G>A allele contributed to a more severe phenotype. This is not unreasonable given these anomalies have been reported in PHS. This study highlights the complicated biology of HH pathway transcription factors and demonstrates the importance of conducting functional experiments when describing GLI3 mutations. Amino acid changes in well-defined domains may in fact influence GLI3 protein function in unexpected ways.
